MedTrace Logo

Efficacy, Safety and Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

NCT04753710 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2022-03-17

Study results available
· View outcomes & findings →

Summary

The study assess efficacy, safety and tolerability of Chloroprocaine 3% ophthalmic gel in healthy volunteers.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Ocular gel

Instillation

Sponsors & Collaborators

  • Sintetica SA

    lead INDUSTRY

Principal Investigators

  • Gerhard Garhoefer · Universitätsklinik für Klinische Pharmakologie

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-29
Primary Completion
2020-11-06
Completion
2020-12-09

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04753710 on ClinicalTrials.gov